Eisai Of Japan To Face Alzheimer's Competition As Others Gear Up
This article was originally published in PharmAsia News
Executive Summary
Japan's Eisai could face competition from Daiichi Sankyo and Switzerland's Novartis for drugs to treat Alzheimer's disease